Statistically Significant Improvements Seen on Two Secondary Endpoints: the Vineland Adaptive Behavior Scale Daily Living Skills (p=0.044) and the Test of Attentional Performance for Children - ...

A prospective cohort study was undertaken using a previously defined and assembled cohort. This cohort had been assembled over an 18-month interval at the Montreal Children's Hospital of the McGill ...

Alcobra Ltd., an emerging pharmaceutical company engaged in development of treatment for cognitive disorders, including attention deficit hyperactivity disorder (ADHD) and Fragile X syndrome (FXS), ...